Plasminogen Activator Inhibitor-1 (PAI-1) is an Essential Driver of Cardiovascular Aging in Mice

被引:0
|
作者
Kalousdian, Anthony
Soberanes, Saul
Eren, Mesut
Jorgensen, Emily
Lux, Elizabeth
Wilsbacher, Lisa D.
Vaughan, Douglas E.
机构
关键词
Aging; Cardiovascular disease; Hypertension; Blood pressure; Cardiovascular Risk;
D O I
10.1161/circ.148.suppl_1.14009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A14009
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Plasminogen Activator Inhibitor-1 Reduces Cardiac Rupture and Prevents Cardiac Remodeling in PAI-1 Transgenic Mice
    Kaneko, Takeaki
    Eren, Mesut
    Vaughan, Douglas E.
    Tsutsui, Hiroyuki
    CIRCULATION, 2009, 120 (18) : S775 - S775
  • [42] REVERSIBLE INTERACTIONS BETWEEN PLASMINOGEN ACTIVATORS (PAS) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    KANEKO, M
    SAKURAMA, T
    MURAKAMI, T
    MATSUDA, M
    SAKATA, Y
    MIMURO, J
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1326 - 1326
  • [43] Homocysteine, plasminogen activator inhibitor-1 (PAI-1), and PAI-1 gene expression in relapsing-remitting multiple sclerosis
    Zea-Sevilla, M. A.
    Carrillo-Padilla, F.
    Fernandez-Sanfiel, M. L.
    Dejuan-Hernández, P.
    MULTIPLE SCLEROSIS, 2007, 13 : S205 - S205
  • [44] Human plasminogen activator inhibitor-1 (PAI-1) deficiency: Characterization of a large kindred with a null mutation in the PAI-1 gene
    Fay, WP
    Parker, AC
    Condrey, LR
    Shapiro, AD
    BLOOD, 1997, 90 (01) : 204 - 208
  • [45] Plasminogen Activator Inhibitor-1 in Aging
    Yamamoto, Koji
    Takeshita, Kyosuke
    Saito, Hidehiko
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (06): : 652 - 659
  • [46] Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in essential thrombocythemia and polycythemia vera and thrombotic complications.
    Cacciola, Rossella R.
    Di Francesco, Ernesto
    Giustolisi, Rosario
    Cacciola, Emma
    BLOOD, 2006, 108 (11) : 306B - 306B
  • [47] VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression:: involvement of the VLDL receptor
    Nilsson, L
    Gåfvels, M
    Musakka, L
    Ensler, K
    Strickland, DK
    Angelin, B
    Hamsten, A
    Eriksson, P
    JOURNAL OF LIPID RESEARCH, 1999, 40 (05) : 913 - 919
  • [48] ELISA SYSTEMS FOR ACTIVE AND TOTAL PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) ANTIGEN
    RESCH, I
    KRUTISCH, G
    GEIGER, M
    BINDER, BR
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 299 - 299
  • [49] Plasminogen Activator Inhibitor-1 (PAI-1) Affects Parietal Epithelial Cell (PECs) Transition
    Ren, G.
    Khusheim, M.
    Yang, H.
    Fogo, A. B.
    LABORATORY INVESTIGATION, 2013, 93 : 391A - 391A
  • [50] Assessment of Plasminogen Activator Inhibitor-1(PAI-1) Biomarker in Women with Breast Cancer Disease
    AL-Nafakh, Zahraa Mohammed
    AL-Dujaili, Arshad Noori G.
    Rudha, Ammar Rasoul Mohammed
    8TH INTERNATIONAL CONFERENCE ON APPLIED SCIENCE AND TECHNOLOGY (ICAST 2020), 2020, 2290